Table 2.
Domain score (%) | |||||||
---|---|---|---|---|---|---|---|
Guideline | Scope and purpose | Stakeholder involvement | Rigor of development | Clarity of presentation | Applicability | Editorial independence | Mean (SD) |
APA | 89.9 | 62.5 | 70.0 | 77.8 | 43.8 | 75.0 | 69.7 (14.1) |
BAP | 80.6 | 61.1 | 47.0 | 75.0 | 50.0 | 79.2 | 65.4 (13.7) |
CANMAT | 80.6 | 62.5 | 53.0 | 94.4 | 27.1 | 66.7 | 64.1 (21.2) |
CPG-S | 100.0 | 93.1 | 83.0 | 80.6 | 85.4 | 83.3 | 87.6 (6.8) |
ICSI | 94.4 | 80.6 | 72.0 | 83.3 | 83.3 | 83.3 | 82.8 (6.7) |
MPG | 80.6 | 40.3 | 45.0 | 88.9 | 68.8 | 25.0 | 58.1 (22.9) |
NICE | 100.0 | 93.1 | 78.0 | 91.7 | 91.7 | 75.0 | 88.3 (8.7) |
RANZCP | 94.4 | 81.9 | 63.0 | 86.1 | 54.2 | 62.5 | 73.8 (14.5) |
TMAP | 72.2 | 31.9 | 27.0 | 88.9 | 60.4 | 41.7 | 53.6 (22.3) |
WFSBP | 86.1 | 63.9 | 70.0 | 80.6 | 39.6 | 70.8 | 68.5 (14.8) |
Mean (SD) | 87.8 (8.9) | 67.1 (19.5) | 60.8 (16.7) | 84.7 (6.0) | 60.4 (20.4) | 66.3 (18.0) |
Abbreviations: APA, American Psychiatric Association; BAP, British Association of Psychopharmacology; CANMAT, Canadian Network for Mood and Anxiety Disorders; CPG-S, Clinical Practice Guidelines in the Spanish NHS; ICSI, Institute for Clinical Systems Improvement; MPG, Maudsley Prescribing Guidelines; NICE, National Institute for Health and Care Excellence; RANZCP, Royal Australian and New Zealand College of Psychiatrists; TMAP, Texas Medication Algorithm Project; WFSBP, World Federation of Societies of Biological Psychiatry.